Dupont Capital Management Corp Clovis Oncology, Inc. Transaction History

Dupont Capital Management Corp

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 26, 2022	SELL	$0.63 - $2.96 $64,592 - $303,479	-102,527 Closed	0 $0
Q1 2022 Apr 27, 2022	BUY	$1.43 - $3.14 $146,613 - $321,934	102,527 New	102,527 $207,000
Q3 2021 Nov 03, 2021	SELL	$4.06 - $5.8 $280,550 - $400,785	-69,101 Closed	0 $0
Q2 2021 Jul 30, 2021	BUY	$5.02 - $7.05 $164,053 - $230,394	32,680 Added 89.73%	69,101 $401,000
Q1 2021 Apr 29, 2021	SELL	$4.81 - $10.34 $35,930 - $77,239	-7,470 Reduced 17.02%	36,421 $256,000
Q4 2020 Jan 28, 2021	SELL	$4.13 - $6.41 $13,529 - $20,999	-3,276 Reduced 6.95%	43,891 $211,000
Q3 2020 Oct 29, 2020	BUY	$4.82 - $7.72 $83,048 - $133,015	17,230 Added 57.55%	47,167 $275,000
Q2 2020 Jul 24, 2020	SELL	$5.69 - $9.69 $15,209 - $25,901	-2,673 Reduced 8.2%	29,937 $202,000
Q4 2019 Jan 27, 2020	BUY	$3.0 - $16.43 $97,830 - $535,782	32,610 New	32,610 $340,000

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of Dupont Capital Management Corp, based on Form 13F filings with the SEC.

Stay updated on Dupont Capital Management Corp with notifications on news.